The core intervention of devices and software has been the subject of peer reviewed research papers and conference presentations, mainly in stroke cohorts. Clinically significant gains in arm function, cognition, mobility and quality of life are recorded. Download the list of publications to date here.

On the strength of pilot studies completed to date, opportunities exist for future research in connection with the use of ableX for stroke, dementia, multiple sclerosis, and cerebral palsy.